Ironwood Pharmaceuticals, Inc. (IRWD)
Upgrades & Downgrades
Latest IRWD news
A Trio of Stocks With High Growth Potential
28 August 2022
Looking for U.S.-listed equities that have the characteristics listed below represents a solid starting point when screening the market for potential value opportunities, in my opinion:
Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q2 2022 Results - Earnings Call Transcript
6 August 2022
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Representatives Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Of...
Ironwood (IRWD) Q2 Earnings Miss, Keeps 2022 Sales Guidance
5 August 2022
Ironwood (IRWD) miss earnings and revenue estimates in the second quarter. Stock declines.
Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call
21 July 2022
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thu...
4 Graham-Style Stocks to Consider
20 June 2022
To increase your chances of discovering value opportunities, you may want to look for stocks whose Graham blended multipliers are below 22.5. Created by Benjamin Graham, the father of value investing,...
Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q1 2022 Results - Earnings Call Transcript
8 May 2022
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ) Q1 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Matt Roache - Director, Investor Relations Tom McCourt - Chief Executive Offi...
Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues
6 May 2022
Ironwood (IRWD) witnesses strong year-over-year sales growth on continued demand for Linzess. Its first-quarter earnings miss estimates.
Ironwood Pharmaceuticals (IRWD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
28 April 2022
Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
2 March 2022
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that management will be presenting at the following investor conferences: Cowen...